Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course. [electronic resource]
Producer: 20081031Description: 117-22 p. digitalISSN:- 1525-4135
- Adenine -- analogs & derivatives
- Adult
- Amino Acid Sequence
- Anti-HIV Agents -- therapeutic use
- CD4 Lymphocyte Count
- Chemoprevention -- methods
- Deoxycytidine -- analogs & derivatives
- Drug Resistance, Viral
- Emtricitabine
- Genotype
- HIV Infections -- physiopathology
- HIV Reverse Transcriptase -- genetics
- HIV Seropositivity
- HIV-1 -- genetics
- HLA Antigens -- genetics
- Humans
- Intestinal Mucosa -- immunology
- Male
- Microbial Sensitivity Tests -- methods
- Molecular Sequence Data
- Organophosphonates -- therapeutic use
- Phylogeny
- Receptors, CCR5 -- genetics
- Sequence Alignment
- Tenofovir
- Time Factors
- Viral Load
- Viremia
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.